Litigation Details for THERAPEUTICSMD, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
✉ Email this page to a colleague
THERAPEUTICSMD, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-08-21 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-09-18 |
| Cause | 28:1338 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Edward S. Kiel |
| Patents | 10,258,630; 10,398,708; 10,471,072; 10,537,581; 10,568,891; 10,668,082; 9,180,091; 9,289,382 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in THERAPEUTICSMD, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for THERAPEUTICSMD, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-08-21 | 1 | Complaint | of U.S. Patent Nos. 9,180,091 (“the ’091 patent”), 9,289,382 (“the ’382 patent”), 10,258,630 (“the ’630…involving U.S. Patent No. 10,668,082 (“the ’082 patent”) (attached as Exhibit A) (“patent-in-suit”). …’630 patent”), 10,398,708 (“the ’708 patent”), and 10,471,072 (“the ’072 patent”). The ’091, ’382, ’630…expiration of U.S. Patent Nos. 10,537,581 (“the ’581 patent”) and 10,568,891 (“the ’891 patent”). The ’581 …expiration of the ’082 patent. The ’082 patent is one (1) of the eight (8) patents listed in FDA’s Orange | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
